Infinium Pharmachem Ltd. (INFINIUM-SM): Infinium Pharmachem Share Price Rises 10% Today

Infinium Pharmachem rose to Rs 244.3, up 10% today, taking its market capitalisation to Rs 354.91 crore and placing the micro-cap Chemicals stock in focus.

Infinium Pharmachem Share Price moved to Rs 244.3 on 25 August 2026, up 10% from the previous close of Rs 222.10, giving the Chemicals company a market capitalisation of Rs 354.91 crore. That move has pushed the stock into today’s market conversation because it qualifies as a notable same-day price rise within its micro-cap category, while also placing the counter among closely watched top gainers today on the NSE.

The supplied data confirms the price event clearly: the stock opened at Rs 229.5, traded between Rs 226.85 and Rs 244.3, and reached its intraday high at the current traded price. Turnover stood at Rs 0.81 crore and total volume was 33,000 shares, all reported on the NSE. For investors scanning Stocks in News and market movers during Stock Market Today, that combination signals a meaningful trading session even though the data does not establish any company-specific catalyst behind the move.

Why is it trending? First, the day’s 10% share price gain is large enough to stand out in Share Market Today screens. Second, Infinium Pharmachem Share Price Today is being assessed against a valuation profile of 28.49 times earnings and 3.16 times book value, with profitability metrics that include ROE of 48.44% and ROCE of 32.14%. Third, investors will now monitor whether price action remains supported by business quality, sector context and relative valuation. In this Univest analysis, the focus stays on verified numbers, price action and fundamental context rather than unsupported speculation.

Infinium Pharmachem Ltd. (INFINIUM-SM) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 244.3
Previous Close	Rs 222.1
Today's Change	+Rs 22.2 (+10%)
Day Open	Rs 229.5
Day High	Rs 244.3
Day Low	Rs 226.85
Current Volume (NSE)	33,000
NSE Traded Volume	33,000
Combined NSE + BSE Volume	33,000
Turnover	Rs 0.81 crore
Market Capitalisation	Rs 354.91 crore
Market Cap Category	Micro Cap

Infinium Pharmachem Ltd. (INFINIUM-SM) traded at Rs 244.3. versus the previous close of Rs 222.1, a rise of 10%. The stock opened at Rs 229.5, reached Rs 244.3, touched Rs 226.85. Reported volume was 33,000.

Infinium Pharmachem Ltd. (INFINIUM-SM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 354.91 crore
P/E Ratio	28.49x
P/B Ratio	3.16x
ROE	48.44%
ROCE	32.14%
EPS	Rs 7.8
Dividend Yield	0%

Infinium Pharmachem Ltd. was valued at a P/E ratio of 28.49x, a P/B ratio of 3.16x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 48.44% and ROCE of 32.14%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 7.8, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Infinium Pharmachem Fundamental Analysis shows a micro-cap Chemicals company with a market capitalisation of Rs 354.91 crore trading at 28.49 times earnings and 3.16 times book value. Those valuation multiples place the stock above some industry medians, while profitability ratios remain notably strong, which helps explain why the price rise is drawing attention.

At the core of the valuation discussion, Infinium Pharmachem Share Price is associated with a P/E ratio of 28.49 and a P/B ratio of 3.16. On their own, these numbers are neither automatically expensive nor inexpensive. They need to be read alongside profitability and sector comparison. Here, return metrics are robust: ROE stands at 48.44% and ROCE at 32.14%. Those are strong absolute numbers and suggest the company has been generating substantial returns on shareholder equity and capital employed relative to many listed businesses.

The earnings base behind the stock is reflected in EPS of 7.8. Since EPS captures earnings attributable to each share, it is an important anchor when the market assigns a 28.49 P/E multiple. A dividend yield of 0 means the current or historical payout contribution to shareholder return is absent in the supplied data, so the investment case, as reflected in today’s market attention, is linked more to price movement and profitability metrics than to income distribution.

Infinium Pharmachem Share Price also needs to be viewed through scale. With a market cap of Rs 354.91 crore, this remains a small listed company in the Chemicals space, so even moderate trading interest can meaningfully affect day-to-day Stock Performance. For Univest, the key takeaway is that the share price rise is not occurring in a vacuum: the valuation profile is supported by high ROE and healthy ROCE, but the stock is still being priced above the industry median P/E and well above the median P/B. That creates a more nuanced picture than a simple momentum headline. The natural next question is how this valuation and profitability profile compares with the wider Chemicals sector and named listed peers.

Sector and Industry Context

Metric	Value
Sector	Chemicals
Industry	Chemicals
Benchmark Scope	same industry
Company P/E Ratio	28.49x
Benchmark Median P/E	20.23x
Benchmark Average P/E	44.56x
Benchmark P/E Range	4.39x to 743.02x
Company P/B Ratio	3.16x
Benchmark Median P/B	1.57x
Company ROE	48.44%
Benchmark Median ROE	12.09%
Company ROCE	32.14%
Benchmark Median ROCE	14.86%
Company Market Capitalisation	Rs 354.91 crore
Benchmark Median Market Cap	Rs 238.16 crore

Infinium Pharmachem Ltd. (INFINIUM-SM) is classified under sector: Chemicals and industry: Chemicals.

Infinium Pharmachem Ltd. (INFINIUM-SM) has a P/E ratio of 28.49x, which is above the benchmark median of 20.23x, a difference of +40.83%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Infinium Pharmachem Ltd. (INFINIUM-SM) has a ROE of 48.44%, which is above the benchmark median of 12.09%, a difference of +300.66%. Infinium Pharmachem Ltd. (INFINIUM-SM) has a ROCE of 32.14%, which is above the benchmark median of 14.86%, a difference of +116.29%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Sector and Industry Context places Infinium Pharmachem Share Price within the listed Chemicals universe, where the company’s valuation and profitability can be tested against a same-industry benchmark of 140 companies. The stock trades on a higher P/E and P/B than the benchmark medians, while its ROE and ROCE are materially stronger than average.

The supplied sector snapshot identifies both sector and industry as Chemicals, with the benchmark defined as the same industry and spanning 140 companies. Within that universe, company P/E is 28.49 against a benchmark median of 20.23 and an average of 44.56, based on 115 companies with P/E data. The benchmark range is wide, from 4.39 to 743.02, which tells investors that valuation dispersion in this industry is significant. Infinium Pharmachem Share Price therefore sits above the median but below the average, suggesting it is not at the most stretched end of the industry’s earnings multiple range.

On price-to-book, the company stands at 3.16 compared with a median of 1.57 and an average of 1.55 across 139 companies. The range runs from -60.92 to 34.7, again highlighting wide variation. That means the stock commands a premium to typical book-value multiples in the industry.

Profitability is where the comparison becomes more favourable. Company ROE is 48.44%, well above the industry median of 12.09% and average of 15.53%, measured across 140 companies. ROCE at 32.14% also exceeds the median of 14.86% and average of 17.84%. In market-cap terms, Infinium Pharmachem at Rs 354.91 crore is above the industry median market capitalisation of Rs 238.16 crore but below the average of Rs 555.21 crore. The full benchmark range stretches from Rs 4.77 crore to Rs 3,168.44 crore. For Univest, this sector picture suggests that the market is paying above-median valuation multiples for a company whose profitability metrics are also well above industry norms.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Grauer & Weil (India) Ltd.	GRAUWEIL	3,168.44	20.23	2.89	14.35	19.47
Bhansali Engineering Polymers Ltd.	BEPL	3,131.88	15.63	2.72	42.11	56.88
Chemplast Sanmar Ltd.	CHEMPLASTS	2,803.28	0	-10.27	0	183.45
Rossari Biotech Ltd.	ROSSARI	2,780.78	18.33	2.03	16.17	24.37
Nocil Ltd.	NOCIL	2,770.94	41.86	1.55	12.95	17.71

Infinium Pharmachem Ltd. (INFINIUM-SM) has a P/E ratio of 28.49x compared with the displayed peer median of 18.33x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.44% compares with a peer median of 14.35% across the companies shown in the table. ROCE stood at 32.14% versus the displayed peer median of 24.37%, providing a capital-efficiency comparison. Infinium Pharmachem Ltd. (INFINIUM-SM) has a market capitalisation of Rs 354.91 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Peer Comparison shows that Infinium Pharmachem Share Price sits in an interesting middle ground. Its market capitalisation is much smaller than the listed peers supplied, but its ROE and ROCE compare favourably with many of them. Valuation, however, is not uniformly cheap relative to this peer set.

Against Grauer & Weil (India) Ltd., which has a market cap of Rs 3,168.44 crore, Infinium Pharmachem trades at a higher P/E of 28.49 versus 20.23 and a slightly higher P/B of 3.16 versus 2.89, while its ROE of 48.44% is far above 14.35% and ROCE of 32.14% is also above 19.47%. Compared with Bhansali Engineering Polymers Ltd., market cap is far lower than Rs 3,131.88 crore and P/E is higher than 15.63, but ROE of 48.44% is above 42.11% even as ROCE of 32.14% trails 56.88%.

Versus Rossari Biotech Ltd., Infinium Pharmachem Share Price carries a richer P/E than 18.33 and a higher P/B than 2.03, but it also posts much stronger ROE and ROCE than Rossari’s 16.17% and 24.37%. Against Nocil Ltd., the company’s P/E of 28.49 is lower than 41.86, yet its P/B of 3.16 is above Nocil’s 1.55, while profitability again looks stronger than Nocil’s ROE of 12.95% and ROCE of 17.71%.

JG Chemicals Ltd. offers another useful reference point. Its P/E is 31.7, above Infinium Pharmachem’s 28.49, and its P/B is 4.3, also above 3.16. Yet Infinium Pharmachem still posts superior ROE at 48.44% versus 29.78% and slightly better ROCE at 32.14% versus 29.05%. This peer set, as reviewed by Univest, suggests that the stock’s valuation is not the lowest in the industry, but its return ratios are competitive and often stronger than larger listed counterparts.

Why Investors Are Watching Infinium Pharmachem

Investors are watching Infinium Pharmachem Share Price because today’s move combines a visible 10% gain with a market-cap profile that can magnify price action, while the underlying financial ratios add substance to the discussion. For traders tracking Top Gainers Today and for longer-term observers looking at Financial Analysis, the stock now sits at the intersection of price action, valuation and profitability.

• The stock rose from Rs 222.10 to Rs 244.3, a one-day gain of Rs 22.2 or 10%.
• It opened at Rs 229.5, stayed above the previous close for the session and touched a high of Rs 244.3.
• Turnover was Rs 0.81 crore on total volume of 33,000 shares on the NSE.
• The company’s market capitalisation stands at Rs 354.91 crore, keeping it in the micro-cap segment.
• P/E is 28.49 and P/B is 3.16, while ROE of 48.44% and ROCE of 32.14% are strong profitability markers.
• The supplied RSI is 45.29, which points to a neutral momentum reading despite the day’s strong price action.
• Within the same-industry Chemicals benchmark, profitability sits well above median and average levels.

The next thing to monitor is whether Infinium Pharmachem Share Price can sustain investor attention through continued price stability, consistent trading participation and a valuation narrative supported by returns metrics. Univest would also watch how the stock’s premium to industry median valuation multiples is weighed against its above-benchmark ROE and ROCE in the coming market update cycle.

About Infinium Pharmachem

About Infinium Pharmachem can be described factually from the supplied classification: the company operates in the Chemicals sector and Chemicals industry, and it is listed under the symbol INFINIUM-SM. While the data set does not provide business-segment or product-level detail, it does establish the market context in which the stock trades and is analysed.

That context matters because Chemicals is a broad listed universe where valuation ranges, profitability profiles and company sizes vary sharply. In the same-industry benchmark of 140 companies, market capitalisations range from Rs 4.77 crore to Rs 3,168.44 crore. Infinium Pharmachem, at Rs 354.91 crore, therefore sits above the industry median size of Rs 238.16 crore but remains far below the larger listed players included in the peer set such as Grauer & Weil, Bhansali Engineering Polymers, Chemplast Sanmar, Rossari Biotech and Nocil.

For readers following Infinium Pharmachem Stock News, that means the company is best understood as a smaller listed Chemicals player whose market behaviour can be more sensitive to session-level demand and supply than large-cap counters. At the same time, the supplied fundamentals show that it is not only a price-action story. The stock carries return metrics of ROE 48.44% and ROCE 32.14%, which place it in a stronger profitability bracket than many peers in the same industry. That combination of micro-cap size and strong reported return ratios helps explain why Infinium Pharmachem Share Price Today is drawing attention across NSE News screens and stock analysis discussions.

Track Infinium Pharmachem Share Price on Univest

Use Infinium Pharmachem Ltd. (INFINIUM-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Readers who want to follow Infinium Pharmachem Share Price more closely can use Univest to track live Share Price movement, day highs and lows, market capitalisation, valuation ratios and broader stock analysis in one place. Univest also helps users monitor company fundamentals such as P/E, P/B, ROE, ROCE, EPS and dividend yield, along with 52-week levels, market insights and ongoing stock updates. For anyone reviewing Infinium Pharmachem Share Price Today, Infinium Pharmachem Share News or Infinium Pharmachem Latest News, the value lies in combining price action with contextual market data rather than reading the move in isolation. That makes Univest a useful reference point for structured monitoring of this Chemicals stock.

Frequently Asked Questions

What is Infinium Pharmachem Share Price today?

Ans. Infinium Pharmachem Share Price today is Rs 244.3. The stock was up 10% from the previous close of Rs 222.10, and the current move places this micro-cap Chemicals company among the notable gainers in today’s session.

Why is Infinium Pharmachem Share Price rising today?

Ans. The supplied data confirms that Infinium Pharmachem Share Price rose 10% today, from Rs 222.10 to Rs 244.3. It also shows the stock opened strong at Rs 229.5, though the data does not establish any company-specific catalyst for the move.

How much did Infinium Pharmachem shares gain in today’s trade?

Ans. Infinium Pharmachem shares gained Rs 22.2 in today’s trade, which translates into a 10% increase over the previous close. The stock moved between Rs 226.85 and Rs 244.3 during the session, ending at the day’s high in supplied data.

What does today’s price action show for Infinium Pharmachem?

Ans. Today’s price action shows a strong session with Infinium Pharmachem opening at Rs 229.5, holding above the previous close of Rs 222.10 and advancing to Rs 244.3. The day low was Rs 226.85, indicating sustained positive intraday positioning.

What is the market capitalisation of Infinium Pharmachem?

Ans. Infinium Pharmachem has a market capitalisation of Rs 354.91 crore. That places it in the micro-cap category, which is relevant because smaller listed companies can often see sharper session-level price moves than larger market-cap stocks.

Is Infinium Pharmachem expensive based on valuation metrics?

Ans. Infinium Pharmachem trades at a P/E of 28.49 and a P/B of 3.16. Its P/E is above the industry median of 20.23 but below the industry average of 44.56, while its P/B is above both median and average levels.

How strong are Infinium Pharmachem’s profitability ratios?

Ans. Profitability ratios are strong on the supplied numbers. ROE stands at 48.44% and ROCE at 32.14%, both comfortably above the Chemicals industry benchmark medians of 12.09% and 14.86%, and also above the corresponding averages.

What are the EPS and dividend yield of Infinium Pharmachem?

Ans. Infinium Pharmachem reports an EPS of 7.8 and a dividend yield of 0 in the supplied data. That means earnings per share are positive, while the present data does not show a dividend yield contribution to shareholder return.

How active was trading volume in Infinium Pharmachem today?

Ans. Trading volume in Infinium Pharmachem stood at 33,000 shares on the NSE, with total volume also at 33,000 shares. Turnover for the session was Rs 0.81 crore, showing measurable participation alongside the stock’s 10% price rise.

How does Infinium Pharmachem compare with Chemicals sector peers?

Ans. Infinium Pharmachem is much smaller than peers like Grauer & Weil, Rossari Biotech and Nocil by market cap, but its ROE of 48.44% and ROCE of 32.14% compare favourably with many larger companies in the supplied peer set.